In January 2019 the Anti-Doping Agency of Kenya (ADAK) has reported an anti-doping rule violation against the Athlete Bernhard Kiplangat Kibilo after his sample tested positive for the prohibited substance 19-norandrosterone (Nandrolone).
After notification a provisional suspension was ordered. The Athlete waived his right for a hearing and the case was settled by the Kenya Sports Disputes Tribunal based on the written submissions of the Parties.
The Athlete admitted the violation and alleged that a substance had been injected in a local clinic as treatment for his muscle injury. The Athlete was unable to indicate the location of the clinic that had been shut down due to operating without a license.
The Tribunal finds that the presence of a prohibited substance had been established in the Athlete’s sample and accordingly that he had committed an anti-doping rule violation.
The Tribunal holds that the Athlete failed to establish that the violation was not intentional nor how the substance had entered his system. He could not show with any evidence the location of the clinic where he underwent medical treatment.
Therefore the Sports Disputes Tribunal decides on 4 February 2021 to impose a 4 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 30 January 2019.
